Viewing StudyNCT00448630



Ignite Creation Date: 2024-05-05 @ 5:23 PM
Last Modification Date: 2024-10-26 @ 9:31 AM
Study NCT ID: NCT00448630
Status: COMPLETED
Last Update Posted: 2022-05-03
First Post: 2007-03-16

Brief Title: An Observational Study On Metabolic Syndrome Parameters In Schizophrenia Patients Treated With Atypical Antipsychotics
Sponsor: Pfizers Upjohn has merged with Mylan to form Viatris Inc
Organization: Pfizer

Conditions & Keywords Data

Conditions:
Name
Metabolic Syndrome X
Schizophrenia
Keywords:
Name View
Atypical antipsychotics View
Metabolic syndrome View
Safety View